Emplois Économie de la Santé » Suède » HEOR Manager Nordic Countries

HEOR Manager Nordic Countries

Stockholm, Sweden.

The HEOR Manager is responsible for the development and execution of high-quality health economic strategic efforts to support optimal reimbursement and market access for Novartis innovative portfolio across the Nordic countries. This involves leveraging HEOR expertise to develop and implement access strategies and project plans with a focus on delivering robust evidence, thereby demonstrating the health economic value of our medicines. The HEOR Manager should have excellent communication and collaboration skills to partner with internal stakeholders both cross-functionally and cross-country, as well as skills to manage external stakeholders (payers, clinicians, decision makers etc.) to secure access for current and future portfolio.

Key responsibilities:
• Lead the efficient and timely development of local HEOR deliverables in alignment with country Value & Access needs, to support successful patient access for the Nordic markets.
• Strategic forward planning to generate robust payer evidence (treatment patterns, real-world efficiency, burden of illness, costing, epidemiology studies, etc.) to support access for our medicines, in close collaboration with Nordic RWE, Medical and Value & Access teams cross-Nordics.
• Coordinate and drive development of HTA-dossiers; from feasibility, data generation, adaptation of health economic models and dossier writing, to post-submission dialogue with HTA-bodies.
• Represent the Value & Access function in cross-functional Nordic pre-launch squads to tailor access strategy, key value story and launch plans across the Nordic countries.
• Maintain expertise and follow trends in HTA/HEOR methodology, in order to guide the Nordic country teams towards access.

Role Requirements

Essential requirements:

• Master’s Degree in Health Economics or related discipline
• Min 3 years of work experience within HTA submissions in a HEOR/HTA/Access role or with HTA-assessments from the payer perspective
• In-depth HEOR technical expertise and experience of health economics modelling
• Strong project management and communication skills
• Self-drive and excellent collaboration skills
• Proven ability to successfully work within a matrix organization
• Fluency in English and one of the Nordic languages

Why Novartis:

Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together?

This job is posted by Novartis.

APPLY FOR JOB

This link brings you to the website of Novartis.

Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!

See also...

Parexel Health Economics jobs

Pricing & Market Access Consultant / Associate

Home-based, Sweden / Hoersholm, Denmark. Other locations: Zealand, Denmark. A Consultant; * must have an ... Read more

Jobs at Biogen for Health economists

Value & Access Country Lead

Upplands Vasby, Sweden. As the Value & Access Country Lead at Biogen, you will spearhead ... Read more

Professional CV review helps you to improve your resume and changes for getting invited for an interview and getting the job you want.

How to Create a Winning CV That Gets You Hired

Tips and tricks to improve your CV and boost your health economics career. Are you ... Read more

Get the Free Weekly Health Economics Jobs Newsletter

8 Reasons Why You Should Sign Up for the Health Economics Jobs Newsletter

Are you a health economist looking for new career opportunities? It can be challenging to ... Read more

Jobs for health economists at PharmaLex

Manager Market Access

Sweden / Denmark. Our Nordic Market Access team is growing and we are looking for ... Read more

Novartis Health Economics jobs

HEOR Manager

Kista, Sweden. Major accountabilities:  Minimum Requirements:  766 million lives were touched by Novartis medicines in ... Read more